摩熵化学
数据库官网
小程序
打开微信扫一扫
首页 分子通 化学资讯 化学百科 反应查询 关于我们
请输入关键词

N-(6-(2-(3-fluorophenyl)piperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)-3-hydroxyazetidine-1-carboxamide | 1218935-35-3

中文名称
——
中文别名
——
英文名称
N-(6-(2-(3-fluorophenyl)piperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)-3-hydroxyazetidine-1-carboxamide
英文别名
N-[6-[2-(3-fluorophenyl)piperidin-1-yl]imidazo[1,2-b]pyridazin-3-yl]-3-hydroxyazetidine-1-carboxamide
N-(6-(2-(3-fluorophenyl)piperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)-3-hydroxyazetidine-1-carboxamide化学式
CAS
1218935-35-3
化学式
C21H23FN6O2
mdl
——
分子量
410.451
InChiKey
HPTIFCCXNOOCCB-UHFFFAOYSA-N
BEILSTEIN
——
EINECS
——
  • 物化性质
  • 计算性质
  • ADMET
  • 安全信息
  • SDS
  • 制备方法与用途
  • 上下游信息
  • 反应信息
  • 文献信息
  • 表征谱图
  • 同类化合物
  • 相关功能分类
  • 相关结构分类

计算性质

  • 辛醇/水分配系数(LogP):
    1.9
  • 重原子数:
    30
  • 可旋转键数:
    3
  • 环数:
    5.0
  • sp3杂化的碳原子比例:
    0.38
  • 拓扑面积:
    86
  • 氢给体数:
    2
  • 氢受体数:
    6

反应信息

  • 作为产物:
    描述:
    6-(2-(3-fluorophenyl)piperidin-1-yl)imidazo[1,2-b]pyridazin-3-amine 、 3-羟基氮杂环丁烷盐酸盐N,N'-羰基二咪唑N,N-二异丙基乙胺 作用下, 以 二氯甲烷 为溶剂, 反应 5.0h, 以51%的产率得到N-(6-(2-(3-fluorophenyl)piperidin-1-yl)imidazo[1,2-b]pyridazin-3-yl)-3-hydroxyazetidine-1-carboxamide
    参考文献:
    名称:
    [EN] SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS
    [FR] COMPOSÉS IMIDAZO[1,2B]PYRIDAZINE SUBSTITUÉS COMME INHIBITEURS DE KINASES TRK
    摘要:
    式(I)化合物:其中R1、R2、R3、R4、X、Y和n的含义如规范中所述,是Trk激酶的抑制剂,并且在治疗可以使用Trk激酶抑制剂治疗的疾病中是有用的。
    公开号:
    WO2010033941A1
点击查看最新优质反应信息

文献信息

  • SUBSTITUTED IMIDAZO[1,2b]PYRIDAZINE COMPOUNDS AS TRK KINASE INHIBITORS
    申请人:Andrews Steven W.
    公开号:US20110166122A1
    公开(公告)日:2011-07-07
    Compounds of Formula (I): in which R 1 , R 2 , R 3 , R 4 , X, Y and n have the meanings given in the specification, are inhibitors of Trk kinases and are useful in the treatment of diseases which can be treated with a Trk kinase inhibitor.
    式(I)的化合物:其中R1、R2、R3、R4、X、Y和n具有规范中给出的含义,是Trk激酶的抑制剂,可用于治疗可用Trk激酶抑制剂治疗的疾病。
  • METHOD OF TREATMENT USING SUBSTITUTED IMIDAZO[1,2B]PYRIDAZINE COMPOUNDS
    申请人:Andrews Steven W.
    公开号:US20130217662A1
    公开(公告)日:2013-08-22
    Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula I in which R 1 , R 2 , R 3 , R 4 , X, Y and n have the meanings given in the specification.
    治疗哺乳动物中的疾病或紊乱的方法,包括疼痛、癌症、炎症、神经退行性疾病、克鲁兹锥虫感染和骨溶解病,其包括向该哺乳动物投与公式I中R1、R2、R3、R4、X、Y和n在说明书中所给定的含义下的化合物的治疗有效量。
  • Method of Treatment Using Substituted Imidazo[1,2b]Pyridazine Compounds
    申请人:Array BioPharma, Inc.
    公开号:US20160251357A1
    公开(公告)日:2016-09-01
    Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula I in which R 1 , R 2 , R 3 , R 4 , X, Y and n have the meanings given in the specification.
    治疗哺乳动物中的疾病或障碍的方法,包括疼痛、癌症、炎症、神经退行性疾病、克鲁茨菌感染和骨溶解疾病,其中包括向该哺乳动物投与有效治疗剂量的I型化合物,其中R1,R2,R3,R4,X,Y和n的含义在规范中给出。
  • Method of treatment using substituted imidazo[1,2B]pyridazine compounds
    申请人:Andrews Steven W.
    公开号:US09227975B2
    公开(公告)日:2016-01-05
    Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula I in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification.
    本发明提供了一种治疗哺乳动物中所选疾病或障碍(包括疼痛、癌症、炎症、神经退行性疾病、克鲁兹锥虫感染和溶骨性疾病)的方法,其包括向该哺乳动物施用化合物I的治疗有效量,其中化合物I的R1、R2、R3、R4、X、Y和n的含义如规范中所示。
  • Method of treatment using substituted imidazo[1,2b]pyridazine compounds
    申请人:Array BioPharma, Inc.
    公开号:US10011604B2
    公开(公告)日:2018-07-03
    Methods for treating a disease or disorder selected from pain, cancer, inflammation, neurodegenerative disease, Typanosoma cruzi infection and osteolytic disease in a mammal, which comprise administering to said mammal a therapeutically effective amount of a compound of Formula I in which R1, R2, R3, R4, X, Y and n have the meanings given in the specification.
    用于治疗哺乳动物疼痛、癌症、炎症、神经退行性疾病、克氏扁虱感染和溶骨性疾病中的疾病或紊乱的方法,包括向所述哺乳动物施用治疗有效量的式 I 化合物 其中 R1、R2、R3、R4、X、Y 和 n 具有说明书中给出的含义。
查看更多